Search

Your search keyword '"Gotti M."' showing total 233 results

Search Constraints

Start Over You searched for: Author "Gotti M." Remove constraint Author: "Gotti M."
233 results on '"Gotti M."'

Search Results

4. FRONTLINE INTENSIFIED ABVD DEMONSTRATES SUPERIOR EFFICACY THAN PET‐ADAPTED ABVD IN ADVANCED HODGKIN LYMPHOMA: THE FIL‐ROUGE PHASE 3 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI

5. EARLY FDG‐PET ADAPTED TREATMENT OF LIMITED STAGE HODGKIN LYMPHOMA (HL): 10Y LONG TERM FOLLOW‐UP ANALYSIS OF THE RANDOMIZED INTERGROUP EORTC/LYSA/FIL H10 TRIAL

7. P1292: MOLECULAR CHARACTERIZATION OF DIFFUSE LARGE B-CELL LYMPHOMA ASSOCIATED TO HEPATITIS C VIRUS INFECTION

8. ESICM LIVES 2016: part one: Milan, Italy. 1-5 October 2016

9. Atomicity and density of Puiseux monoids

12. Phase 2 KEYNOTE‐B68 study: pembrolizumab every 6 weeks in relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) or primary mediastinal B‐cell lymphoma (PMBCL).

17. Study on the antibacterial properties of leathers tanned with natural tannins and their interactions with shoes inhabiting bacteria

22. OUTCOME AND TREATMENT OF RELAPSING EARLY PET NEGATIVE PATIENTS INCLUDED IN THE EORTC/LYSA/FIL H10 TRIAL ON STAGES I/II HODGKIN LYMPHOMA

23. PS1090 OBINUTUZUMAB DOES NOT COMPROMISE MOBILIZATION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN LYMPHOMA PATIENTS: RESULTS FROM A FIL PROSPECTIVE PHASE II STUDY (THE GIOTTO STUDY)

24. 37th International Symposium on Intensive Care and Emergency Medicine (part 1 of 3)

25. THE PROGNOSTIC ROLE OF CELL OF ORIGIN PROFILE AND OVEREXPRESSION OF MYC ASSESSED BY IMMUNOHISTOCHEMISTRY IN YOUNG HIGH-RISK PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS OF FIRST LINE RANDOMIZED BIO-DLCL04 TRIAL OF FONDAZIONE ITALIANA LINFOMI

26. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned

27. Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

28. BIODLCL04: THE PROGNOSTIC ROLE OF CELL OF ORIGIN PROFILE, MYC, BCL2, AND TP53 IN UNTREATED POOR-RISK DIFFUSE LARGE B-CELL LYMPHOMA

29. DIRECT-ACTING ANTIVIRALS DURING OR AFTER IMMUNO-CHEMOTHERAPY IN HEPATITIS C VIRUS-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMAS

30. Baseline‐PET derived metrics are the most relevant factors for risk stratification in early‐stage nonbulky HL: preliminary results of the RAFTING trial.

33. TAU ELEVATIONS IN THE BRAIN EXTRACELLULAR SPACE CORRELATE WITH REDUCED AMYLOID-B LEVELS AND PREDICT ADVERSE CLINICAL OUTCOMES AFTER SEVERE TRAUMATIC BRAIN INJURY

34. La lettera androgina: Karoline von Günderrode

35. Alcune osservazioni sulle lettere di Theodor W. Adorno a Thomas Mann. Ruoli, intepretazioni, forzature

36. Particles as grammaticalized complex predicates

37. The balance between syntax and discourse in Old English

38. The origins of the Northern Subject Rule

41. Outcome of Transformed Marginal Zone Lymphomas Treated in the Rituximab Era

42. Fact or Fallacy? English as a lingua franca in the European business context

43. Introduction

44. Bespoke/su misura

48. Il pellet di castagno detannizzato

49. Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial

50. Special Issue: Intercultural discourse in domain-specific English

Catalog

Books, media, physical & digital resources